Hepatocellular carcinoma (HCC) is a well-studied T cell-inflamed cancer with abundant tumor-infiltrating nonefficient antitumor CD8+ T cells, which suggests improving the antitumor function of infiltrated CD8+ T cells is of greater significance in HCC than increasing the infiltration of CD8+ T cells [17]. This evidence concerns the gene CD8A and neoplasm.